640 filings
Page 21 of 32
8-K
btkt738i yz4osf
19 Jun 12
Other Events
12:00am
8-K
k5d80eial17eqsxk
4 Jun 12
ZIOPHARM Oncology Completes Enrollment in PICASSO 3 Trial Evaluating Palifosfamide in Front-Line Metastatic Soft Tissue Sarcoma
12:00am
8-K
nbrj 5bgvj2ji6xky5b
10 May 12
ZIOPHARM Oncology Appoints Jason A. Amello as Executive Vice President and Chief Financial Officer
12:00am
8-K
6av1psnkvp
3 May 12
ZIOPHARM Reports First Quarter Financial Results
12:00am
8-K
7byaw7
3 Apr 12
Departure of Directors or Certain Officers
12:00am
8-K
9h7y4p51y lg1pq
3 Apr 12
ZIOPHARM Oncology Presents Compelling Data Showing Palifosfamide Activity in Breast Cancer Models at AACR Meeting
12:00am
8-K
0w47hf ghzvf0tv6s6i3
2 Apr 12
Program Committee Recognizes Presentation as Among the Best Science at AACR
12:00am
8-K
hhu3ket8 5g5uh76vgu
2 Apr 12
ZIOPHARM Oncology Provides Update on PICASSO 3 Trial
12:00am
8-K
tq1kqkf
29 Feb 12
ZIOPHARM Reports Fourth Quarter and Full Year 2011 Financial Results
12:00am
8-K
tnnhx2mkl 5lm
14 Feb 12
ZIOPHARM Oncology Reports Positive Preliminary Palifosfamide Overall Survival Data from Randomized Phase 2 Study in Soft Tissue Sarcoma
12:00am
424B3
2tossk4ub3vb91zc0
3 Feb 12
Prospectus supplement
12:00am
8-K
r7dk13o
25 Jan 12
ZIOPHARM Oncology Prices Public Offering of Common Stock
12:00am
424B5
80l giih0ct
23 Jan 12
Prospectus supplement for primary offering
12:00am
8-K
z6c3kb14wt8he2bxd
20 Jan 12
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
12:00am
FWP
fmn6jmm2goot61uqa
20 Jan 12
Free writing prospectus
12:00am
424B5
11e78c2 ebb66a9v5t
19 Jan 12
Prospectus supplement for primary offering
12:00am
8-K
wgovdb0c
11 Jan 12
30 th Annual J.P. Morgan Healthcare Conference Jonathan Lewis, MD, PhD Chief Executive Officer Better Cancer Medicine
12:00am